<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Matboli M</submitter><funding>Ain Shams Faculty of Medicine</funding><pagination>46-55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7324892</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>The aim of this study was to explore the expression of exosomal non-coding RNAs (ncRNAs) in the sera of patients with HCC &lt;i>versus&lt;/i> control.&lt;h4>Methods&lt;/h4>Firstly, Bioinformatics analysis was conducted to retrieve ncRNAs specific to HCC (hsa-miRNA-1298 and lncRNA-RP11-583F2.2). Afterwards, extraction and characterization of exosomes were performed. We measured the expression of the chosen exosomal RNAs by reverse transcriptase quantitative real-time PCR in sera of 60 patients with HCC, 42 patients with chronic hepatitis C (CHC) infection and 18 healthy normal volunteers.&lt;h4>Results&lt;/h4>The exosomal ncRNAs [hsa-miRNA-1298, lncRNA-RP11-583F2.2] had better sensitivity and specificity than alpha-fetoprotein (AFP) in HCC diagnosis.&lt;h4>Conclusion&lt;/h4>The exosomal hsa-miRNA-1298, lncRNA-RP11-583F2.2 can be potential biomarkers for HCC diagnosis.</pubmed_abstract><journal>Current genomics</journal><pubmed_title>Exosomal miR-1298 and lncRNA-RP11-583F2.2 Expression in Hepato-cellular Carcinoma.</pubmed_title><pmcid>PMC7324892</pmcid><funding_grant_id>2016-36</funding_grant_id><pubmed_authors>Ali-Labib R</pubmed_authors><pubmed_authors>Matboli M</pubmed_authors><pubmed_authors>Nasser HE</pubmed_authors><pubmed_authors>Habib EK</pubmed_authors><pubmed_authors>El-Tawdi AHF</pubmed_authors><pubmed_authors>Labib ME</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exosomal miR-1298 and lncRNA-RP11-583F2.2 Expression in Hepato-cellular Carcinoma.</name><description>&lt;h4>Aim&lt;/h4>The aim of this study was to explore the expression of exosomal non-coding RNAs (ncRNAs) in the sera of patients with HCC &lt;i>versus&lt;/i> control.&lt;h4>Methods&lt;/h4>Firstly, Bioinformatics analysis was conducted to retrieve ncRNAs specific to HCC (hsa-miRNA-1298 and lncRNA-RP11-583F2.2). Afterwards, extraction and characterization of exosomes were performed. We measured the expression of the chosen exosomal RNAs by reverse transcriptase quantitative real-time PCR in sera of 60 patients with HCC, 42 patients with chronic hepatitis C (CHC) infection and 18 healthy normal volunteers.&lt;h4>Results&lt;/h4>The exosomal ncRNAs [hsa-miRNA-1298, lncRNA-RP11-583F2.2] had better sensitivity and specificity than alpha-fetoprotein (AFP) in HCC diagnosis.&lt;h4>Conclusion&lt;/h4>The exosomal hsa-miRNA-1298, lncRNA-RP11-583F2.2 can be potential biomarkers for HCC diagnosis.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-04T13:38:27.549Z</modification><creation>2025-04-04T13:38:27.549Z</creation></dates><accession>S-EPMC7324892</accession><cross_references><pubmed>32655298</pubmed><doi>10.2174/1389202920666191210111849</doi></cross_references></HashMap>